NMNAT2 and cancer: Sharif et al. (2016) [59] explained that NMNAT2 is a key enzyme in a salvage pathway via p73 for the cancer cell viability, which may verify the important role of NMNAT2 for the RTK inhibitor treatment on breast cancer cells.